Menu
Services
Subscription
Membership
Datafeeds/API
Public Fund Monitor
Advertising
Consulting
Quarterly
News
Policy
Deals
Europe
Asia
Real Estate
Alternatives
Real Assets
Public Pension
Private Equity
Energy
Crypto
Infrastructure
Fund Rankings
SWF
Public Pension
Bank
Endowment
Central Bank
Superannuation
Foundation
Manager Rankings
Asset Manager
Bank
Financial Holding Company
Crypto
Wealth Manager
Hedge Fund Manager
Profiles
SWF
Public Pension
Superannuation
Endowment
Central Bank
State-Owned Enterprise
Family Office
Afore
Transactions
Listed Equity
Unlisted Equity
Real Estate
Private Equity Fund
Real Estate Fund
Credit Fund
Infrastructure
Active Equities
RFPs
Active Equities
Active Fixed Income
Private Equity Fund
Real Estate Fund
Credit Fund
Real Estate
Hedge Fund
Consultant
Events
Demo
Login
Searched:
"Vir Biotechnology"
Institutional Investor and Sovereign Wealth Fund News Stories
Home
News
Searched
"Vir Biotechnology"
Current News
Page 1 of 1
08/15/2023
Temasek Dumped High Risk U.S. Biotech and Crypto-Related Stocks by June 30, 2023
05/21/2021
DAILY DOSE: May 21, 2021
04/06/2020
GlaxoSmithKline Gets Closer to Vir Biotechnology with Pan-Coronavirus Collaboration and Equity Investment
04/02/2020
Mubadala Ventures Plans to Form Healthcare Fund Amid Coronavirus Pandemic
03/18/2020
Brewing Chaos at the SoftBank Vision Fund as Virus Pandemic Causes Strain for Major Portfolio Companies
05/09/2018
SoftBank Vision Fund Scores $29.7 Billion in Acquisition Costs at Year-End
Get News, People, and Transactions, Delivered to Your Inbox
Your Email:
Sign Up
Search news stories
Perform Search